Flucloxacillin Capsules BP 500mg
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 3 recall · DMRC-39902702
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Flucloxacillin Capsules BP 500mg | PL: 43461/0071 | flucloxacillin sodium | 5060464503320 |
Batches (expiry): 1600636 (31/08/2028)
Background: Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin BP 500mg Capsules. Flamingo Pharma UK Ltd estimate that the number of impacted is low however as a precautionary measure, this batch is being recalled. Advice for Healthcare Professionals: Stop supplying the affected batch. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.